Aminopeptidase A is a functional target in angiogenic blood vessels

Cancer Cell

Volumn 5, Issue 2, 2004, Pages 151-162

  Marchiò, Serena ^a,b   Lahdenranta, Johanna ^a   Schlingemann, Reinier O ^c   Valdembri, Donatella ^b   Wesseling, Pieter ^d   Arap, Marco A ^a   Hajitou, Amin ^a   Ozawa, Michael G ^a   Trepel, Martin ^a,i   Giordano, Ricardo J ^a   Nanus, David M ^e   Dijkman, Henri B P M ^d   Oosterwijk, Egbert ^d   Sidman, Richard L ^f   Cooper, Max D ^g,h   Bussolino, Federico ^b   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CYSTEINYLPROLYLARGINYLGLUTAMYLCYSTEINYLGLUTAMYLSERYLISOLEUCYLCYSTEINE; GLUTAMYL AMINOPEPTIDASE; GROWTH FACTOR; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYMOLOGY; HYPOXIA; INHIBITION KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR; UPREGULATION;

ANIMALIA;

EID: 10744220098     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(04)00025-X     Document Type: Article

References (48)

1. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., Lawley T.J. HMEC-1. establishment of an immortalized human microvascular endothelial cell line J. Invest. Dermatol. 99:1992;683-690.
2. Alliot F., Rutin J., Leenen P.J., Pessac B. Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J. Neurosci. Res. 58:1999;367-378.
3. Arap W., Pasqualini R., Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science. 279:1998;377-380.
4. Arap W., Kolonin M.G., Trepel M., Lahdenranta J., Cardó-Vila M., Giordano R.J., Mintz P.J., Ardelt P.U., Yao V.J., Vidal C.I.et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 8:2002;121-127.
5. Assmann K.J.M., van Son J.P.H.F., Dijkman H.B.P.M., Koene R.A.P. A nephritogenic rat monoclonal antibody to mouse aminopeptidase A. Induction of massive albuminuria after a single intravenous injection. J. Exp. Med. 175:1992;623-635.
6. Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:2003;1287-1295.
7. Burg M.A., Pasqualini R., Arap W., Ruoslahti E., Stallcup W.B. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res. 59:1999;2869-2874.
8. Bussolino F., Arese M., Montrucchio G., Barra L., Primo L., Benelli R., Sanavio F., Aglietta M., Ghigo D., Rola-Pleszczynski M.R.et al. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest. 96:1995;940-952.
9. Deroanne C.F., Hajitou A., Calberg-Bacq C.M., Nusgens B.V., Lapiere C.M. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res. 57:1997;5590-5597.
10. Ebert T., Bander N.H., Finstad C.L., Ramsawak R.D., Old L.J. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res. 50:1990;5531-5536.
11. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:2002;161-174.
12. Fujimura H., Ino K., Nagasaka T., Nakashima N., Nakazato H., Kikkawa F., Mizutani S. Aminopeptidase A expression in cervical neoplasia and its relationship to neoplastic transformation and progression. Oncology. 58:2000;342-352.
13. Geng Y., Biffi A., Engelstein D., Ronch E., Faustini M., Lai H.K., Albino A.P., Di Fronzo G., Nanus D.M. Expression of the kidney-associated differentiation glycoprotein gp160 and resistance to the antitumor effects of interferon alpha in renal cell carcinomas. Anticancer Res. 18:1998;1-7.
14. Giordano R.J., Cardó-Vila M., Lahdenranta J., Pasqualini R., Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7:2001;1249-1253.
15. Hajitou A., Sounni N.E., Devy L., Grignet-Debrus C., Lewalle J.M., Li H., Deroanne C.F., Lu H., Colige A., Nusgens B.V.et al. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2. effect on in vivo mammary tumor growth and angiogenesis Cancer Res. 61:2001;3450-3457.
16. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364.
17. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., McDonald D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156:2000;1363-1380.
18. Ino K., Nagasaka T., Okamoto T., Uehara C., Nakazato H., Nakashima N., Mizutani S. Expression of aminopeptidase A in human gestational choriocarcinoma cell lines and tissues. Placenta. 21:2000;63-72.
19. Jackson E.K. Renin and Angiotensin. Hardman J.G., Limbird L.E., Goodman Gilman A. Goodman and Gilman's The Pharmacological basis of therapeutics. 2001;809-841 McGraw-Hill Medical Publishing Division, New York.
20. Kifor I., Dzau V.J. Endothelial renin-angiotensin pathway. evidence for intracellular synthesis and secretion of angiotensins Circ. Res. 60:1987;422-428.
21. Koivunen E., Arap W., Valtanen H., Rainisalo A., Medina O.P., Heikkilä P., Kantor C., Gahmberg C.G., Salo T., Konttinen Y.T.et al. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17:1999;768-774.
22. Lahdenranta J., Pasqualini R., Schlingemann R.O., Hagedorn M., Stallcup W.B., Bucana C.D., Sidman R.L., Arap W. An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc. Natl. Acad. Sci. USA. 98:2001;10368-10373.
23. Le Noble F.A., Kessels-van Wylick L.C., Hacking W.J., Slaaf D.W., oude Egbrink M.G., Struijker-Boudier H.A. The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J. Vasc. Res. 33:1996;480-488.
24. Li L., Wu Q., Wang J., Bucy R.P., Cooper M.D. Widespread tissue distribution of aminopeptidase A, an evolutionarily conserved ectoenzyme recognized by the BP-1 antibody. Tissue Antigens. 42:1993;488-496.
25. Lin Q., Taniuchi I., Kitamura D., Wang J., Kearney J.F., Watanabe T., Cooper M.D. T and B cell development in BP-1/6C3/aminopeptidase A-deficient mice. J. Immunol. 160:1998;4681-4687.
26. McCarty M.F., Baker C.H., Bucana C.D., Fidler I.J. Quantitative and qualitative in vivo angiogenesis assay. Int. J. Oncol. 21:2002;5-10.
27. Mentzel S., van Son J.P., Dijkman H.B., Wetzels J.F., Assmann K.J. Induction of albuminuria in mice. synergistic effect of two monoclonal antibodies directed to different domains of aminopeptidase A Kidney Int. 55:1999;1335-1347.
28. Monton M., Castilla M.A., Alvarez Arroyo M.V., Tan D., Gonzalez-Pacheco F.R., Lopez Farre A., Casado S., Caramelo C. Effects of angiotensin II on endothelial cell growth. role of AT-1 and AT-2 receptors J. Am. Soc. Nephrol. 9:1998;969-974.
29. Morikawa S., Baluk P., Kaidoh T., Haskell A., Jain R.K., McDonald D.M. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160:2002;985-1000.
30. Murphy A.N., Unsworth E.J., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157:1993;351-358.
31. Nadal J.A., Scicli G.M., Carbini L.A., Scicli A.G. Angiotensin II stimulates migration of retinal microvascular pericytes. involvement of TGF-beta and PDGF-BB Am. J. Physiol. Heart Circ. Physiol. 282:2002;739-748.
32. Nanus D.M., Engelstein D., Gastl G.A., Gluck L., Vidal M.J., Morrison M., Finstad C.L., Bander N.H., Albino A.P. Molecular cloning of the human kidney differentiation antigen gp160. human aminopeptidase A Proc. Natl. Acad. Sci. USA. 90:1993;7069-7073.
33. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 380:1996;364-366.
34. Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M., Stryhn A., Ashmun R.A., Shapiro L.H., Arap W., Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60:2000;722-727.
35. Ribatti D., Gualandris A., Bastaki M., Vacca A., Iurlaro M., Roncali L., Presta M. New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. the gelatin sponge/chorioallantoic membrane assay J. Vasc. Res. 34:1997;455-463.
36. Sang Q.X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8:1998;171-177.
37. Schlingemann R.O., Dingjan G.M., Emeis J.J., Blok J., Warnaar S.O., Ruiter D.J. Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 52:1985;71-76.
38. Schlingemann R.O., Rietveld F.J., Kwaspen F., van de Kerkhof P.C., de Waal R.M., Ruiter D.J. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1991;1335-1347.
39. Schlingemann R.O., Oosterwijk E., Wesseling P., Rietveld F.J., Ruiter D.J. Aminopeptidase a is a constituent of activated pericytes in angiogenesis. J. Pathol. 179:1996;436-442.
40. Smith G.P., Scott J.K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:1993;228-257.
41. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., D'Amore P.A. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 35:1994;101-111.
42. St. Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science. 289:2000;1197-1202.
43. Volpert O.V., Ward W.F., Lingen M.W., Chesler L., Solt D.B., Johnson M.D., Molteni A., Polverini P.J., Bouck N.P. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J. Clin. Invest. 98:1996;671-679.
44. Walsh D.A., Hu D.E., Wharton J., Catravas J.D., Blake D.R., Fan T.P. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br. J. Pharmacol. 120:1997;1302-1311.
45. Wesseling P., Schlingemann R.O., Rietveld F.J., Link M., Burger P.C., Ruiter D.J. Early and extensive contribution of pericytes/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme. an immuno-light and immuno-electron microscopic study J. Neuropathol. Exp. Neurol. 54:1995;304-310.
46. Wu Q., Lahti J.M., Air G.M., Burrows P.D., Cooper M.D. Molecular cloning of the murine BP-1/6C3 antigen. a member of the zinc-dependent metallopeptidase family Proc. Natl. Acad. Sci. USA. 87:1990;993-997.
47. Yoshiji H., Kuriyama S., Kawata M., Yoshii J., Ikenaka Y., Noguchi R., Nakatani T., Tsujinoue H., Fukui H. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis. possible role of the vascular endothelial growth factor Clin. Cancer Res. 7:2001;1073-1078.
48. Zempo N., Koyama N., Kenagy R.D., Lea H.J., Clowes A.W. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol. 16:1996;28-33.